The Asia and Australasia influenza vaccines market is anticipated to reach nearly US$ 1.5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.
In the Asia and Australasia influenza vaccines market, Japan accounts for majority of the market share. Japan is expected to remain the clear leader in influenza vaccines market throughout the forecasting period. China is the second leading market for influenza vaccines market with around XX% share in 2015. India and South Korea are the third and fourth leading market for influenza vaccines. Australia, Thailand, Singapore and New Zealand are the other leading market for influenza vaccines.
In the influenza vaccines brand sales segment, Sanofi’s Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK’s Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.
Check the Discount for this Report @ http://orbisresearch.com/contacts/discount/175210 .
iGATE Research report titled “Asia and Australasia Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021” provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 121 Page report contains 61 Figures and 8 Tables to present a clear picture of the influenza vaccines market landscape.
The Influenza Vaccines Market have been analyzed from 5 viewpoints:
1. Asia and Australasia Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 – 2021)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast – Country Wise Distribution (2011 – 2021)
3. Influenza Vaccines Brand Sales and Forecast to 2021
4. Influenza Vaccines Market – Major Deals
5. Influenza Vaccines Market – Driving Factors and Challenges
Request a Sample of this Report @ http://orbisresearch.com/contacts/request-sample/175210 .
Some Points from List of Tables:
Table 3-1: Country Wise – Influenza Vaccines Market Share (Percent), 2011 – 2015
Table 3-2: Country Wise – Forecast for Influenza Vaccines Market Share (Percent), 2016 – 2021
Table 3-3: Country Wise – Persons Vaccinated with Influenza Vaccines Share (Percent), 2011 – 2015
Table 3-4: Country Wise – Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2016 – 2021
Table 6-1: Global – Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 – 2015
Table 6-2: Global – Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 – 2015
Table 7-1: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations
Table 7-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019